Qi-dong X. Xia
No.1095 Jiefang Avenue
Wuhan, 430030, China
Wuhan, 430030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications
First-in-human single-cell and TCR atlas reveals peripheral immune remodeling before and after irreversible electroporation in prostate cancer.
Journal: Journal for immunotherapy of cancer
Published: April 13, 2026
Magnetically Navigated and PSMA/STEAP1 Dual-Targeted Nanoliposomes for NIR-II/MRI Imaging with Photothermal-Chemo-Immunotherapy for Prostate Cancer.
Journal: Research (Washington, D.C.)
Published: March 09, 2026
Corrigendum to "Escherichia coli Nissle 1917 outer membrane vesicles encapsulating oncolytic virus remodel tumor-associated macrophages and kill prostate cancer cells" [Journal of Controlled Release Volume 390, 10 February 2026, 114514/ COREL-D-25-06760].
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: January 22, 2026
Oncolytic virus OH2 induces PD-L1 upregulation via NF-κB signaling and synergizes with anti-PD-L1 therapy in prostate cancer through a targeted extracellular vesicle delivery system.
Journal: Journal for immunotherapy of cancer
Published: January 09, 2026
PSMA PET/MRI-US Fusion-Guided Irreversible Electroporation for Focal Therapy of Prostate Cancer.
Journal: Clinical nuclear medicine
Published: December 17, 2025
Proteolysis-targeting Chimeras induce ferroptosis in cancer: From Mechanism to clinical application.
Proteolysis-targeting Chimeras induce ferroptosis in cancer: From Mechanism to clinical application.
Journal: Pharmacological research
Published: December 15, 2025
Escherichia coli Nissle 1917 outer membrane vesicles encapsulating oncolytic virus remodel tumor-associated macrophages and kill prostate cancer cells.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 26, 2025
Therapeutic translation of traditional Chinese medicine Huangqi derived exosome like nanoparticles: targeting prostate cancer through ferroptosis activation, immune reprogramming, and microbiome modulation.
Journal: Journal of nanobiotechnology
Published: August 07, 2025
Irreversible electroporation for localized prostate cancer: risk-stratified oncologic outcomes and functional preservation.
Journal: Prostate international
Published: July 24, 2025
Targeting the HSP60/p53 Axis with Extracellular Vesicle-Delivered siRNA Reprograms Glycolysis in Prostate Cancer.
Journal: International journal of biological sciences
Published: July 02, 2025
Efficacy of oncolytic virus in the treatment of intermediate-to-advanced solid tumors: a systematic review and meta-analysis.
Journal: Journal of virology
Published: June 20, 2025
Last Updated: 09/26/2026